Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
Gibson CJ, Lindsley RC, Tchekmedyian V, Mar BG, Shi J, Jaiswal S, Bosworth A, Francisco L, He J, Bansal A, Morgan EA, Lacasce AS, Freedman AS, Fisher DC, Jacobsen E, Armand P, Alyea EP, Koreth J, Ho V, Soiffer RJ, Antin JH, Ritz J, Nikiforow S, Forman SJ, Michor F, Neuberg D, Bhatia R, Bhatia S, Ebert BL. Gibson CJ, et al. Among authors: nikiforow s. J Clin Oncol. 2017 May 10;35(14):1598-1605. doi: 10.1200/JCO.2016.71.6712. Epub 2017 Jan 9. J Clin Oncol. 2017. PMID: 28068180 Free PMC article.
Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Oluwole OO, Dholaria B, Knight TE, Jain T, Locke FL, Ramsdell L, Nikiforow S, Hashmi H, Mooney K, Bhaskar ST, Morris K, Gatwood K, Baer B, Anderson LD Jr, Hamadani M. Oluwole OO, et al. Among authors: nikiforow s. Transplant Cell Ther. 2024 Feb;30(2):131-142. doi: 10.1016/j.jtct.2023.11.008. Epub 2023 Nov 10. Transplant Cell Ther. 2024. PMID: 37951502 Review.
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma.
Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT, Gallagher K, Maus MV. Choi BD, et al. Among authors: nikiforow s. N Engl J Med. 2024 Apr 11;390(14):1290-1298. doi: 10.1056/NEJMoa2314390. Epub 2024 Mar 13. N Engl J Med. 2024. PMID: 38477966
Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies.
Nikiforow S, Frigault MJ, Frey NV, Gardner RA, Komanduri KV, Perales MA, Kebriaei P, Warkentin PI, Pasquini M, Aho JL, Levine BL, Heslop HE, Hlucky TL, Habucky K, Gharibo M, Jagasia M, Locke FL. Nikiforow S, et al. Transplant Cell Ther. 2023 Apr;29(4):228-239. doi: 10.1016/j.jtct.2023.01.021. Epub 2023 Jan 26. Transplant Cell Ther. 2023. PMID: 36709800 Free article.
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.
Nikiforow S, Kim HT, Bindra B, McDonough S, Glotzbecker B, Armand P, Koreth J, Ho VT, Alyea EP 3rd, Blazar BR, Ritz J, Soiffer RJ, Antin JH, Cutler CS. Nikiforow S, et al. Biol Blood Marrow Transplant. 2013 May;19(5):804-11. doi: 10.1016/j.bbmt.2013.02.009. Epub 2013 Feb 14. Biol Blood Marrow Transplant. 2013. PMID: 23416855 Free PMC article. Clinical Trial.
Targeting Epstein-Barr virus-associated lymphomas.
Nikiforow S, Lacasce AS. Nikiforow S, et al. J Clin Oncol. 2014 Mar 10;32(8):830-2. doi: 10.1200/JCO.2013.53.2994. Epub 2014 Feb 3. J Clin Oncol. 2014. PMID: 24493729 No abstract available.
Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survival.
Koreth J, Kim HT, Nikiforow S, Milford EL, Armand P, Cutler C, Glotzbecker B, Ho VT, Antin JH, Soiffer RJ, Ritz J, Alyea EP 3rd. Koreth J, et al. Among authors: nikiforow s. Biol Blood Marrow Transplant. 2014 Oct;20(10):1516-21. doi: 10.1016/j.bbmt.2014.05.025. Epub 2014 Jun 4. Biol Blood Marrow Transplant. 2014. PMID: 24907627 Free PMC article.
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.
Herrera AF, Kim HT, Bindra B, Jones KT, Alyea EP 3rd, Armand P, Cutler CS, Ho VT, Nikiforow S, Blazar BR, Ritz J, Antin JH, Soiffer RJ, Koreth J. Herrera AF, et al. Among authors: nikiforow s. Biol Blood Marrow Transplant. 2014 Nov;20(11):1737-43. doi: 10.1016/j.bbmt.2014.06.040. Epub 2014 Jul 10. Biol Blood Marrow Transplant. 2014. PMID: 25017765 Free PMC article. Clinical Trial.
121 results